Artos app on Android does provide XIRR values. It also imports your statement from zerodha and upstox to build your portfolio. Not available on iOS yet, but looks like a good app to try
Posts tagged Value Pickr
INOX Wind (22-11-2023)
I was thinking about the Inox Wind Ltd merger with holding co’ Inox Wind Energy Ltd and decided to write down what’s happening on the front, mainly to structure my own thinking because on the day of the announcement I had initiated a tracking position on IWEL
5 months down the line I wanted to know if my thesis was intact and I think If the merger goes through at current share prices, IWEL is like a discount coupon on purchase of Inox Wind Ltd
The rationale for the same along with merger arbitrage math has been explained in more detail on my substack in case you’re interested.
Would love to hear feedback on the same. Thanks
Rahul
CG Power & Industrial Solutions – Capable management, good business & industry tailwinds (22-11-2023)
How long does it take for commission of this project usually?
Titagarh Rail Systems – Is this train finally moving? (22-11-2023)
ABB India has formed a strategic partnership with Titagarh Rail Systems Ltd for the supply of propulsion systems for metro rolling stock projects in India.
Titagarh will also secure the manufacturing rights and production licence for traction motors, along with the complete transfer of technology for the GoA 4 (driverless metro) TCMS software from ABB.
Fine Organics – Niche Player in Specialty Chemical (22-11-2023)
Have had a detailed call with SGA which handle Fine’s investor relations. Important points to note:
-
The way they defined fine’s products are through the following analogy: Say you want to cook Chicken. You just need handful of spices as a proportion of total volume of chicken. But these handful spices in small amount, makes big difference. Similarly, fine’s products provide the finished touches in such a way that it is not possible to manufacture the final products without them
-
There are a couple of competitors in the oleochemical based additives. However, the bouquet of products which are present with Fine is huge. Hence the MNC’s tend to go with the supplier having a range of products rather than a singular product
-
They sign the contract with MNC’s for the supply. This contract can be short term or long term depending upon the prevailing price of raw material. When the raw material prices are high, the customers tend to sign short contract vis a vis long contracts when the prices are low
-
SGA iterated that 28% EBITDA displayed is unsustainable. The prime reason was a lot of inventory of raw material undertaken during lockdown which got sold for high prices in 2021 due to raw material inflation. These contracts were short term
-
Contracts are up for renewal this quarter. The prime objective of the customers would be to sign long term contracts this time since RM prices have normalized. Going forward there might be the pressure in margins
-
One should expect a steady state 18%-20% EBITDA. China has no impact on this business since it is highly specialized. The application of these products are in a mission critical sector, hence the suppliers cannot be changed easily
-
Although the content of Fine Organics <0.8% by weight in the final composition, still they do not enjoy pricing power (as opposed to what is claimed by Marcellus). The MNC’s always treat them as “just a raw material provider”.
Mutual Fund specific to Foreign Giants (22-11-2023)
Hey, looking for an Indian Mutual Fund specifically focused on Foreign Bluechip stocks like Apple, Tesla, Microsoft… on similar lines.
One with full focus on these and not a part allotted to them with other Indian listed stocks.
20 Microns – potential multibagger (22-11-2023)
The growth is sales is on the lower side, but there is improvement in the EBIDTA margins. Going forward, need to see how they do on reducing power & fuel cost, also the where the freight charges are going.
Liquidity of the stock one should be wary of, also if company comes with some big CAPEX plan for near future that should also be kept in view.
Sumitomo Chemicals ~ After Excel Crop Care Acquisition (22-11-2023)
valuations across the agro chem space seem to attractively priced currently – just for context if we see the results from Bayer , Basf , GAVL etc : Risk to Reward seems favourable for Sumitomo Chem : one pertinent point ref Glyphosate hearing on 7th dec 23 company management believes that regulatory restrictions are unlikely
Biocon – The ultimate biosimilars play! (22-11-2023)
True. Appears to be very attractively valued when one looks at sum of parts (three biz) valuations
Syngene – Listed
Generic – Look at Concord Biotech
These two itself should justify current valuations. Biosimilars seems to be free.